HALEON PLC ORD GBP0.01 - stock earnings
HLN.L Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 36.5 billion GBp | 279.8 billion GBp |
| 2023Q2 | 29.8 billion GBp | 275.2 billion GBp |
| 2023Q1 | 38.9 billion GBp | 298.6 billion GBp |
| 2022Q4 | 19.8 billion GBp | 379.3 billion GBp |
| 2022Q3 | 34.5 billion GBp | 289.2 billion GBp |
| 2022Q2 | 20.1 billion GBp | 256.1 billion GBp |
| 2022Q1 | 258.5 million GBP | 2.6 billion GBP |
| 2021Q2 | 258.0 million GBP | 2.3 billion GBP |
| 2021Q1 | 245.5 million GBP | 2.3 billion GBP |
HLN.L Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 106.0 billion GBp | 1.1 trillion GBp |
| 2021 | 139.0 billion GBp | 954.5 billion GBp |
| 2020 | 114.5 billion GBp | 989.2 billion GBp |
| 2019 | 65.5 billion GBp | 848.0 billion GBp |
HLN.L
Price: £3.30
52 week price:
Dividend Yield: 0.00%
5-year range yield:
Forward Dividend Yield: 2.55%
Payout Ratio: 7636.36%
Payout Ratio Range:
Dividend Per Share: 8.40 GBp
Earnings Per Share: 0.11 GBp
P/E Ratio: 24.57
Exchange: LSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 17.0 million
Market Capitalization: 29.5 billion
Years Paying Dividends: 2